Table 1.

Patient demographics and clinical characteristics

	Arm
	Treatment (N=10)	Sham (N=8)	Total (N=18)	P-value
Age at On Study				0.92901
N	10	8	18
Mean (SD)	56.0 (11.17)	56.8 (5.95)	56.3 (8.98)
Median	59.5	56.5	57.5
Range	35.0, 72.0	45.0, 63.0	35.0, 72.0
Prior Radiation, n (%)				0.34162
Prior Radiation	3 (30.0%)	5 (62.5%)	8 (44.4%)
No Prior Radiation	7 (70.0%)	3 (37.5%)	10 (55.6%)
Type of cancer, n (%)				1.00002
Cervical	2 (20.0%)	1 (12.5%)	3 (16.7%)
Endometrial	4 (40.0%)	3 (37.5%)	7 (38.9%)
Ovarian	3 (30.0%)	3 (37.5%)	6 (33.3%)
Vaginal	1 (10.0%)	0 (0.0%)	1 (5.6%)
Vulvar	0 (0.0%)	1 (12.5%)	1 (5.6%)
Histology, n (%)				0.17532
Adenocarcinoma	6 (60.0%)	3 (42.9%)	9 (52.9%)
Other	3 (30.0%)	0 (0.0%)	3 (17.6%)
Serous Carcinoma	1 (10.0%)	2 (28.6%)	3 (17.6%)
Squamous Cell Carcinoma	0 (0.0%)	2 (28.6%)	2 (11.8%)
Missing	0	1	1
Stage, n (%)				0.71902
I	0 (0.0%)	1 (12.5%)	1 (5.9%)
IA	5 (55.6%)	3 (37.5%)	8 (47.1%)
IB	1 (11.1%)	1 (12.5%)	2 (11.8%)
II	1 (11.1%)	1 (12.5%)	2 (11.8%)
IIB	1 (11.1%)	0 (0.0%)	1 (5.9%)
III	0 (0.0%)	2 (25.0%)	2 (11.8%)
IIIB	1 (11.1%)	0 (0.0%)	1 (5.9%)
Missing	1	0	1
Chemotherapy, n (%)				0.58462
No	3 (33.3%)	1 (14.3%)	4 (25.0%)
Yes	6 (66.7%)	6 (85.7%)	12 (75.0%)
Missing	1	1	2
Surgery, n (%)				1.00002
No	1 (10.0%)	0 (0.0%)	1 (5.6%)
Yes	9 (90.0%)	8 (100.0%)	17 (94.4%)
Vaginal Lubricant Use, n (%)				0.15152
No	7 (87.5%)	1 (33.3%)	8 (72.7%)
Unknown	0 (0.0%)	1 (33.3%)	1 (9.1%)
Yes	1 (12.5%)	1 (33.3%)	2 (18.2%)
Missing	2	5	7
Vaginal Moisturizer Use, n (%)				0.09092
No	8 (100.0%)	2 (50.0%)	10 (83.3%)
Unknown	0 (0.0%)	2 (50.0%)	2 (16.7%)
Missing	2	4	6
Vaginal Estrogen Use, n (%)				0.05172
No	8 (88.9%)	1 (25.0%)	9 (69.2%)
Unknown	0 (0.0%)	2 (50.0%)	2 (15.4%)
Yes	1 (11.1%)	1 (25.0%)	2 (15.4%)
Missing	1	4	5

¹Kruskal-Wallis p-value

²Fisher Exact p-value